Healthcare Compliance

CMS Medicaid State Plan Eligibility Comment Period Ends May 6

CMS is seeking public comment on a revised Medicaid State Plan Eligibility template (CMS-10434 #15, OMB control number 0938-1188) that incorporates changes under section 71109 of the Working Families Tax Cut (WFTC) legislation, limiting federal financial participation for full Medicaid coverage to U.S. citizens or nationals and specific noncitizen groups (lawful permanent residents, Cuban/Haitian entrants, and COFA migrants). The revised template includes required attestations for emergency Medicaid coverage and coverage during the reasonable opportunity period pending verification of citizenship or immigration status. Comments must be received by May 6, 2026, and will be considered by CMS before finalization.

CMS External Quality Review Regulations for Medicaid, CHIP

CMS is seeking public comment on a revision to an existing approved information collection under the Paperwork Reduction Act, specifically for External Quality Review (EQR) activities related to Medicaid and CHIP managed care. The collection involves 681 respondents generating 7,236 responses annually and accounting for 887,086 total annual hours. Comments must be submitted to the OMB desk officer by May 22, 2026.

CMS-R-185 Deeming Authority and CLIA Exemption PRA Notice

CMS published a 60-day Paperwork Reduction Act notice inviting public comment on two information collection packages related to the Clinical Laboratory Improvement Amendments (CLIA) program. The first package (CMS-R-26, OMB Control No. 0938-0612) is a revision covering CLIA laboratory regulations including personnel and histocompatibility requirements, with 49,626 respondents and 14,514,802 total annual hours. The second package (CMS-R-185) is an extension covering the granting and withdrawal of deeming authority for private nonprofit accreditation organizations and CLIA exemptions for state laboratory programs under 42 CFR part 493. Comments must be received by June 22, 2026.

CLIA Regulations (CMS-R-26) Comment Period Ends June 22

CMS published a 60-day Paperwork Reduction Act notice announcing the opportunity for public comment on two CLIA-related information collection requests. The first is a revision of the currently approved CMS-R-26 collection (OMB Control No. 0938-0612), covering CLIA regulations with 49,626 respondents and 14,514,802 total annual burden hours. The second is an extension of deeming authority for private nonprofit accreditation organizations and state laboratory programs under CLIA. Comments must be submitted by June 22, 2026.

Direct Entry Midwifery Legend Drugs and Devices Proposed Rules Comments Due April 30

The Oregon Health Authority Health Licensing Office and Board of Direct Entry Midwifery have filed proposed administrative rules governing legend drugs and devices for direct entry midwives. The proposed rules require applicants to pass a written examination plus three skills examinations covering injection administration, intravenous therapy, and suturing before licensure. Currently licensed direct entry midwives must retake both the written and skills assessment examinations every three years for license renewal. Comments will be accepted through April 30 2026 at noon with a public hearing scheduled for April 29 2026 from 10 a.m. to noon. Permanent rules are scheduled to become effective July 1 2026.

Board of Sign Language Interpreters Meeting April 20, 2026

The Oregon Health Authority's Board of Sign Language Interpreters has scheduled a public meeting for Monday, April 20, 2026 at 9:30 a.m. The notice warns that the meeting may be canceled if one or more new SLI Board members are not appointed before the meeting date, or if the requisite number of sign language interpreters have not confirmed availability and attendance within 48 hours of the meeting. Information on public attendance is available through the HLO Public Meetings page.

1.2 Million Eligible for NHS Wegovy to Cut Heart Attack and Stroke Risk

NICE published draft guidance recommending semaglutide (Wegovy) as a treatment option for people with cardiovascular disease who are overweight or obese (BMI 27 or higher) and have previously had a heart attack, stroke, or peripheral arterial disease. The NHS has struck a deal making the treatment cost-effective, with approximately 1.2 million eligible patients in England able to receive the weekly injection from summer 2026. Clinical trial data showed a 20% reduction in serious heart problems compared to placebo.

Spring COVID-19 Vaccinations Now Available for Millions of Vulnerable People in England

The NHS spring COVID-19 vaccination programme has launched, offering doses to eligible adults aged 75 and over, care home residents, and people who are immunosuppressed. Appointments are available daily at GP practices and community pharmacies across England, with booking options via the NHS App, NHS website, walk-in sites, or by calling 119. As of March 2023, COVID-19 vaccines had saved an estimated 475,000 lives in England and Scotland according to a study cited in the COVID-19 Inquiry.

Record 2.43M A&E Attendances in March 2026, Five-Year Waiting Time Low

NHS England reported that A&E departments saw a record 2.43 million attendances in March 2026, 16,000 more than the previous high in May 2024, driven in part by a meningitis outbreak mid-month. Despite the surge, 77.1% of patients were seen within four hours—the best performance since July 2021—with ambulance response times averaging 26:18 for the most serious incidents. The total waiting list fell to 7.22 million, a decrease of 31,006 from January and over 400,000 since July 2024, while 80.5% of suspected cancer patients received a diagnosis or all-clear within 28 days.

Virtual Measles Briefing, Oregon, 1 p.m. April 17

Oregon Health Authority and Oregon Health & Science University physicians will provide an update on measles during a virtual media briefing at 1 p.m. on Friday, April 17, 2026. Speakers include Dean Sidelinger, M.D., M.S.Ed., health officer and state epidemiologist at OHA's Public Health Division, and Dawn Nolt, M.D., MPH, professor of pediatric infectious diseases at OHSU's Doernbecher Children's Hospital. They will discuss latest measles data, recent OHA advisories on exposure locations, work with local public health authorities on case investigations, and wastewater surveillance data.

Virtual Measles Briefing With OHA, OHSU Physicians, April 17

Oregon Health Authority and Oregon Health & Science University physicians will host a virtual media briefing on measles at 1 p.m. on Friday, April 17, 2026. Speakers include Dean Sidelinger, M.D., health officer and state epidemiologist at OHA's Public Health Division, and Dawn Nolt, M.D., MPH, professor of pediatric infectious diseases at OHSU's Doernbecher Children's Hospital. Reporters can join via Zoom while a public livestream will be available via YouTube.

Renewal, Growth of Spring a Great Time to 'Rethink the Drink'

The Oregon Health Authority (OHA) on April 16, 2026, issued a public awareness announcement recognizing Alcohol Awareness Month in April, encouraging Oregonians to reflect on the role alcohol plays in their daily lives. The announcement highlights that more than one in five Oregonians drink excessively, contributing to approximately 3,000 alcohol-related deaths each year. OHA directs residents to its Rethink the Drink initiative for resources on healthier drinking habits.

North Dakota HHS $3.6M Rural Health Transformation Grants

North Dakota HHS announced three new grant opportunities totaling $3.6 million through its Rural Health Transformation Program: Zero-Hour Physical Education ($700K), Community Gardens ($300K), and Community-Based Walking Programs ($2.6M). Applications will be accepted from April 22 through May 22, 2026, at 5 p.m. CT. The grants are funded by a $199 million CMS award to North Dakota, with award ranges from $10,000 to $125,000 each and potential renewal up to five years for successful recipients.

Iowa Fetal Heartbeat Law Guidance for Healthcare Professionals

The Iowa Department of Inspections, Appeals, and Licensing has issued guidance to clarify physician obligations under Iowa's Fetal Heartbeat Law, signed July 14, 2023, which prohibits abortion after detection of a fetal heartbeat via transabdominal pelvic ultrasound. Physicians must document both informed consent under Iowa Code § 146A.1 and fetal heartbeat testing in the patient's medical record. The guidance clarifies exceptions for rape (must be reported within 45 days), incest (reported within 140 days), medical emergencies, and fetal abnormalities incompatible with life.

Historical Program Memoranda 2000-2003 Medicare Guidance

CMS has published an archive index of Program Memoranda issued between 2000 and 2003, during the period when CMS operated under its former name HCFA. The index lists 32 memoranda covering topics including Medicare payment policies, HIPAA compliance requirements, rural health clinic payment rates, ambulance fee schedules, and claims processing rules. Several entries are marked as rescinded or retracted. These memoranda communicated one-time, non-recurring action items or information requests to Medicare contractors and providers.

MFT Licensure Forms, Applications, Supervised Experience, Policies, Guidelines

The Texas Behavioral Health Executive Council (TX BBHE), through the Texas State Board of Examiners of Marriage and Family Therapists, has published updated forms and publications for MFT licensure on its public webpage. The posted materials include applications for licensure with required-document checklists, supervised experience verification forms, military service forms, and miscellaneous forms such as reinstatement checklists and SAVE verification. The page also hosts policies and guidelines covering social media use, technology-assisted services, and new and emerging practice or technology guidelines.

Texas Behavioral Health Council, Board Meeting Schedules

The Texas Behavioral Health Executive Council maintains a public-facing page listing upcoming and past meeting schedules for the Council and its five member boards: the Texas State Board of Examiners of Marriage and Family Therapists, the Texas State Board of Examiners of Professional Counselors, the Texas State Board of Examiners of Psychologists, and the Texas State Board of Social Worker Examiners. The page informs the public that meeting notices are filed with the Texas Register and are accessible via the Open Meeting Viewer, and that agendas and supporting materials are typically published 7 business days before each meeting. Since May 2021, the Council has transitioned from written meeting minutes to audio/video recordings of open meetings, which are available on the Council's YouTube channel or via public information request. No new compliance obligations or regulatory changes are described.

DSH Department Letters on IST, Diversion, and CONREP Programs

CA DSH publishes a collection of departmental letters providing operational guidance to stakeholders on three forensic mental health programs: Incompetent to Stand Trial (IST), Conditional Release Program (CONREP), and Diversion. The collection includes letters dating from 2019 to 2025, with Letter 25-001 covering a new process for IST out-of-custody individuals, Letter 25-002 superseding prior diversion funding guidance, and Letter 23-003 superseding the IST Growth Cap methodology. Letters 22-001, 22-002, 23-002, and 24-003 are explicitly noted as superseded by subsequent letters. The page also includes growth cap methodology attachments, dispute processes, and rate/tier information.

DSH Regulations Governed by California Statutes

The California Department of State Hospitals publishes an index of its regulatory actions governed by California statutes, including one proposed regulation (State Hospital Visitation Process under regular rulemaking) and 21 completed regulations spanning 2016–2025. Completed regulations cover areas including patient property, contraband, enhanced treatment programs, sexually violent predator assessments, court evaluator appointments, and end-of-life options, with effective dates ranging from April 2016 to December 2025. Comments on proposed regulations may be submitted via email or U.S. Mail to the Regulations and Policy Unit.

CA DSH Patient Demographics and Forensic vs Civil Commitment Population Data Published

The California Department of State Hospitals published access to two datasets via the California Health and Human Services Agency Open Data Portal: patient demographics broken down by age groups from Fiscal Years 2010 to 2018, and forensic versus civil commitment population counts. The page also links to annual reports (2016–2018), hospital violence reports spanning 2010–2020, quarterly seclusion and restraint data, and State Leadership Accountability Act reports.

David E. Brown Appointed Director of Virginia Department of Health Professions

Governor Abigail Spanberger appointed David E. Brown, D.C. as Director of the Virginia Department of Health Professions. Dr. Brown returns to DHP after two previous terms as Director, serving under former Governors Ralph Northam and Terry McAuliffe. He is a Virginia native and former Charlottesville mayor with a healthcare career dating back to 1982, including service on the Virginia Board of Medicine and Virginia Healthcare Workforce Development Authority.

Virginia DHP Unveils Three New Healthcare Dashboards

The Virginia Department of Health Professions (DHP) and its Healthcare Workforce Data Center (HWDC) have unveiled three interactive dashboards providing data on healthcare supply and demand, behavioral health trends, and career pathways for students. These tools are designed to inform and empower healthcare workforce planning across the Commonwealth of Virginia. This announcement does not create any new compliance obligations for healthcare providers or other entities.

Virginia DHP Accelerates Licensing, Expands Behavioral Health Careers

Over three years, DHP has sharply reduced Board of Medicine licensing timelines from 88 to 34 days overall, accelerating workforce entry where it is needed most. Two new behavioral health license types—behavioral health technician and behavioral health technician assistant—are now available, with the psychological practitioner license forthcoming, while Registered Peer Recovery Specialist numbers have more than doubled. Dentistry licenses are now issued in as little as two days compared to 30 days previously, and a new public dashboard provides real-time behavioral health workforce data.

EP4167901A1 Implant Fixation Device for Urinary Continence

The European Patent Office published EP4167901A1 on April 15, 2026, granted to Uromedica, Inc. for an implantable device fixation system designed for urinary continence. The patent names John H. Burton and Timothy C. Cook as inventors and classifies the invention under IPC categories A61F 2/00, A61B 17/12, and A61B 17/00. The designation covers all EPO member states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.

EP4126518A1: Intraocular Lens Production Method, Carl Zeiss Meditec AG

The EPO published patent application EP4126518A1 for Carl Zeiss Meditec AG on April 15, 2026, covering a method for producing an intraocular lens and a production device. The applicant is Carl Zeiss Meditec AG with inventor Michael Thaller. The patent carries IPC classifications including B29D 11/00 (optical article manufacturing), B29C 64/124 (additive manufacturing), and A61F 2/16 (intraocular lenses), and is designated across all EU member states including DE, FR, GB, IT, NL, ES, and 25 others.

Boston Scientific Scimed Implant Patent EP3973921A1 for Pelvic Conditions

The European Patent Office has published patent application EP3973921A1, filed by Boston Scientific Scimed, Inc., covering implants and tools for treatments of pelvic conditions. The application names Thomas O. Viker as inventor and carries IPC classification A61F 2/00. The patent is designated across all listed contracting states and grants exclusive rights to the patented technology from the publication date.

Edwards Lifesciences Heart Valve Sealing Devices Patent, EP4037613A1

The European Patent Office published patent application EP4037613A1 for Edwards Lifesciences Corporation covering heart valve sealing devices and delivery devices therefor (IPC A61F 2/24). The application names Lauren R. Freschauf and Eric Michael Oberwise as inventors, with 36 designated contracting and extension states covering the full EU territory plus additional countries. The patent publication took effect on April 15, 2026.

Karl Storz SE Tympanostomy Tube EP4051196A1

The European Patent Office published patent application EP4051196A1 for a tympanostomy tube filed by Karl Storz SE & Co. KG. The inventors are John Vaughan, Olive O'Driscoll, and Carol Grimes. The patent was published on April 15, 2026, and covers the designated states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR. IPC classifications include A61F 11/00 and A61F 9/007.

Heart Valve Assembly, Venus MedTech, Published 15th Apr

EPO published patent application EP3957279A1 for a Heart Valve Assembly filed by Venus MedTech (HangZhou), Inc. The application names ZENG, Min, Frank and LO, Pham as inventors, with the invention classified under IPC A61F 2/24. The patent has received designation across all EPO member states, establishing intellectual property protection for the prosthetic heart valve technology.

Accommodating Intraocular Lenses With Combination of Mechanical Driving Components

The European Patent Office granted patent EP3968901A1 to Akkolens International B.V. on 15 April 2026 for accommodating intraocular lenses incorporating a combination of mechanical driving components. The patent, invented by ROMBACH, Michiel Christiaan and VAN LAWICK, Willem Pieter, covers the optical design and mechanical actuation mechanism enabling lens accommodation. The A1 publication includes a European search report and designates all contracting states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

Takeda Pharmaceutical - Implantable Cell Chamber Device, EP4120958A1

The European Patent Office granted Takeda Pharmaceutical Company Limited Patent EP4120958A1 titled 'Implantable Cell Chamber Device and Uses Thereof,' published April 15, 2026. The patent application (filed by inventors LING, Vincent, IMAICHI, Sachiko, PHANEUF, Matthew, LONG, Nathaniel, KASSAB, Rayan, and ROBERTSON, Robbie James) covers technology related to implantable cell chamber devices and their therapeutic applications, with IPC classifications spanning prosthetics (A61F), biomedical materials (A61L), and therapeutic agents (A61P) including gastrointestinal applications. The patent is designated across 31 European member states including Germany, France, the United Kingdom, Italy, Spain, the Netherlands, Belgium, Austria, and Switzerland.

Ottobock Prosthetic Foot Component Patent, EP3914195A1 Granted

Ottobock SE & Co. KGaA has been granted European Patent EP3914195A1 for a prosthetic foot component, published April 15, 2026 by the European Patent Office. The patent covers the technical design and functionality of the prosthetic device, with inventors including Martin Pusch and designated coverage across all EU member states and extension states.

EPO Publishes Stent-Graft Patent EP3777768A1, W.L. Gore

The European Patent Office published patent EP3777768A1 titled 'Stent-Graft Having Facing Side Branch Portals' assigned to W.L. Gore & Associates, Inc. (inventor: Edward E. Shaw). The patent, classified under A61F 2/07, A61F 2/95, and A61F 2/89, designates protection across 31 European states including Germany, France, the United Kingdom, Italy, Spain, and 26 others. This publication grants exclusive rights to the applicant's stent-graft design with facing side branch portals for vascular applications.

Fluid-Filled Intraocular Lens Delivery Method, Alcon Inc

Alcon Inc. filed EP3928744A1 with the EPO on April 15, 2026, covering a method for advancing a fluid-filled intraocular lens within a delivery device. Gregory Vinton Matthews is listed as the sole inventor. The application (Kind A1, meaning published with search report) designates all EU member states plus the United Kingdom. This represents a new patent application publication in the ophthalmic surgical device field.

Edwards Lifesciences EPO Implant Adhering Patent

The European Patent Office published patent application EP4076282A1 titled 'Implant Adhering Techniques' by Edwards Lifesciences Innovation (Israel) Ltd. (inventor: Shlomit CHAPPEL-RAM), covering A61F cardiac and A61B surgical implant technologies. The patent designates 38 European states including DE, FR, GB, IT, NL, ES, BE, CH, SE, PL, AT, and IE. The grant confers exclusive rights to the patent holder to make, use, and sell the claimed implant-adhering techniques throughout designated EPO member states for the patent term.

Texas Medicaid Recipients Can Self-Direct Long-Term Care Services

Texas Medicaid recipients can self-direct long-term care services through the Consumer Directed Services (CDS) option, which allows them to hire and manage their own service providers. The CDS option originated as a 1997 pilot authorized by the 75th Texas Legislature and was later codified by Senate Bill 1586, 76th Legislature, into Texas Administrative Code, Chapter 264. Multiple Medicaid programs including Community Living Assistance and Support Services, Home and Community-based Services, STAR Kids, and STAR+PLUS now participate in the CDS option, offering services such as personal care, nursing, therapy, employment assistance, and respite.

Texas ALF Types, Services, Licensing, Regulatory Resources

Texas HHS provides an informational overview of Assisted Living Facilities (ALFs), categorizing them as Type A (for residents who can follow emergency directions without nighttime attendance) or Type B (for residents requiring staff assistance and nighttime attendance). The page lists applicable statutes including Texas Health and Safety Code Chapter 247 and TAC Title 26 Chapter 553, along with resources such as a provider directory, training courses, webinars, and contact numbers for the Licensing and Certification Unit at 512-438-2630.

HCS Program Services Texans Intellectual Disabilities

The Texas Health and Human Services Commission publishes this HCS (Home and Community-based Services) Program page as the primary informational hub for providers serving Texans with intellectual disabilities. The page consolidates applicable federal statutes (Social Security Act §1915(c)) and state administrative rules (TAC Title 26, Chapters 263, 264, 565; TAC Title 1, Chapter 352), provider forms, and a mandatory GovDelivery email subscription requirement for contracted providers. Archived webinar recordings (including Feb. 18, 2026 and Oct. 29, 2025 sessions) are available, along with contact information for HCS policy, contracting, eligibility, and regional nursing staff.

CHIP State Plan Eligibility Comment Period Ends May 6

CMS has issued a Paperwork Reduction Act notice seeking public comment on a revised information collection for CHIP State Plan Eligibility (CMS-10398 #17, OMB control 0938-1148). The revision incorporates changes under section 71109 of the Working Families Tax Cut legislation, which limits federal financial participation for full CHIP coverage to U.S. citizens, U.S. nationals, and three groups of FFP-eligible noncitizens (lawful permanent residents, Cuban/Haitian entrants, and COFA migrants). The update modifies the Non-Financial Eligibility—Citizenship template (CS 18) and its Implementation Guide. Comments must be received by May 6, 2026; affected public consists of 56 state, local, or tribal government respondents with an estimated 2,800 total annual hours burden.

CMS Information Collection Request, Comments Due May 22nd

CMS is announcing a 30-day public comment period under the Paperwork Reduction Act regarding a proposed information collection for External Quality Review (EQR) of Medicaid and CHIP Managed Care. The collection involves Form CMS-R-305 (OMB control number 0938-0786) affecting 681 respondents across the private sector and State, Local, or Tribal Governments, with an estimated total annual burden of 887,086 hours. Comments must be received by the OMB desk officer by May 22, 2026.

CMS Requests Comment on CLIA Information Collections by June 22

The Centers for Medicare & Medicaid Services published a Federal Register notice announcing a 60-day comment period under the Paperwork Reduction Act for two Clinical Laboratory Improvement Amendments (CLIA) information collections. The first item is a revision of CLIA Regulations (OMB Control No. 0938-0612) covering quality assessment, fees, histocompatibility, and personnel requirements, with approximately 49,626 respondents and 14,514,802 total annual hours. The second item is an extension of the collection on granting and withdrawal of deeming authority for private nonprofit accreditation organizations and CLIA exemption under state laboratory programs. Comments are due June 22, 2026.

OIG Review of Medicare Clinical Diagnostic Laboratory Test Payments 2025

HHS OIG announced a new work plan project (OEI-09-26-00220) to conduct an annual analysis of the top 25 laboratory tests by Medicare expenditures for 2025, as required by the Protecting Access to Medicare Act of 2014 (PAMA). The review is currently in-progress under the Office of Evaluation and Inspections, with an estimated completion date of fiscal year 2028. CMS began paying for lab tests under the PAMA-mandated system on January 1, 2018, using current charges in the private healthcare market under Title XVIII of the Social Security Act.

EPO Publishes Intraoral OCT Color Texture Imaging Patent Application

The European Patent Office published application EP3644832A1 titled 'INTRAORAL OCT WITH COLOR TEXTURE' on April 15, 2026. The application covers intraoral optical coherence tomography imaging systems that incorporate color texture processing for dental applications. The applicant is Dental Imaging Technologies Corporation.

Fluid Collection Medical Device EP3755225A1

The European Patent Office granted patent EP3755225A1 to LHM Innovations Pty Ltd on April 15, 2026, for a fluid collection medical device. The invention is classified under IPC category A61B (measurement/detection for diagnosis) and designates 37 contracting states across the EPO member framework.

Riverfield Arm Device EP3777641A1

The European Patent Office published patent EP3777641A1 for an ARM DEVICE, assigned to Riverfield Inc. The invention relates to robotic arm technology for diagnostic and surgical applications, classified under A61B 1/00, A61B 90/50, A61B 34/30, A61B 17/00, and B25J 9/06. The patent names HARAGUCHI, Daisuke, TADANO, Kotaro, and KANAZAWA, Noriaki as inventors, with designated states covering all major European jurisdictions.

Motion-Compensated Medical Imaging Device Patent EP3677186A1

The European Patent Office granted Patent EP3677186A1 to Siemens Healthineers AG for a motion-compensated medical imaging device and system. The patent, invented by Alois Regensburger and Jessica Magaraggia, covers technology to generate motion-compensated images for diagnostic purposes. The patent is designated for all listed European member states.

EP3731740A1 - Acclarent Anatomical Distance Monitoring System

The EPO published European patent application EP3731740A1 titled 'Monitoring Distance to Selected Anatomical Structures During a Procedure' filed by Acclarent, Inc. and Biosense Webster (Israel) Ltd. The A1 publication includes the international search report. The application covers medical devices for real-time anatomical distance tracking during surgical procedures under IPC classifications A61B 5/00, A61B 5/06, and A61B 1/233.

Galvani Bioelectronics Inflammation Treatment Patent Application EP3727570A1

The EPO published patent application EP3727570A1 filed by Galvani Bioelectronics Limited for systems and methods of treating disorders associated with inflammation using bioelectronic approaches. The application covers electrical stimulation devices targeting inflammatory conditions and names six inventors. The patent designates 32 European states including all current EU member states plus Albania, Norway, Switzerland, and other EPC contracting states.

Abbott Diabetes Care Analyte Sensor EP3542712A1 Published

The European Patent Office published patent application EP3542712A1 for Abbott Diabetes Care Inc., titled 'Analyte Sensor and Apparatus for Insertion of the Sensor.' The patent application covers A61B diagnostic and A61M medical device technologies including analyte sensors, insertion apparatus, and associated control systems. The application is designated for all 35 EU member states and extension states.